ArticleJournal for immunotherapy of cancer2021

Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19-IL2 cures poorly immunogenic tumors when combined with radiotherapy.

Veronica Olivo Pimentel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.